Living Cell Technologies Stock Return On Equity
| LVCLF Stock | USD 0 0.00 0.00% |
Living Cell Technologies fundamentals help investors to digest information that contributes to Living Cell's financial success or failures. It also enables traders to predict the movement of Living Pink Sheet. The fundamental analysis module provides a way to measure Living Cell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Living Cell pink sheet.
Living |
Living Cell Technologies Company Return On Equity Analysis
Living Cell's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Living Cell Return On Equity | -0.72 |
Most of Living Cell's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Living Cell Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Living Cell Technologies has a Return On Equity of -0.7233. This is 96.98% lower than that of the Healthcare sector and 98.02% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 133.32% higher than that of the company.
Living Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Living Cell's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Living Cell could also be used in its relative valuation, which is a method of valuing Living Cell by comparing valuation metrics of similar companies.Living Cell is currently under evaluation in return on equity category among its peers.
Living Fundamentals
| Return On Equity | -0.72 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (428.70) % | |||
| Current Valuation | 12.53 M | |||
| Shares Outstanding | 1.29 B | |||
| Shares Owned By Insiders | 33.99 % | |||
| Price To Earning | (31.67) X | |||
| Price To Book | 6.96 X | |||
| Price To Sales | 5,587 X | |||
| Revenue | 3.4 K | |||
| Gross Profit | 3.4 K | |||
| EBITDA | (2.38 M) | |||
| Net Income | (1.96 M) | |||
| Cash And Equivalents | 4.24 M | |||
| Total Debt | 228.44 K | |||
| Debt To Equity | 0.10 % | |||
| Current Ratio | 17.84 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (2.04 M) | |||
| Earnings Per Share | (0) X | |||
| Number Of Employees | 15 | |||
| Beta | 0.27 | |||
| Market Capitalization | 9.81 M | |||
| Total Asset | 4.27 M | |||
| Retained Earnings | (67 M) | |||
| Working Capital | 5 M | |||
| Current Asset | 6 M | |||
| Current Liabilities | 1000 K | |||
| Z Score | 5.4 | |||
| Net Asset | 4.27 M |
About Living Cell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Living Cell Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Living Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Living Cell Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Living Pink Sheet
Living Cell financial ratios help investors to determine whether Living Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Living with respect to the benefits of owning Living Cell security.